Skip to main content

Table 3 Homogeneity test for general characteristics and measurement variables at baseline (mean ± standard deviation)

From: Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial

Characteristic

Bimin decoction group (n = 51)

Control group (n = 47)

푃 value

Age (years)

36.8 ± 11.6

37.9 ± 10.2

0.523

Male/female

29/22

26/21

0.221

TNSS (score)

 Overall

7.84 ± 1.46

8.43 ± 1.56

0.062

 Sneezing

2.22 ± 0.67

2.28 ± 0.71

0.608

 Runny nose

2.06 ± 0.79

2.23 ± 0.76

0.265

 Itchy nose

1.90 ± 0.94

2.19 ± 0.74

0.141

 Nasal obstruction

1.67 ± 0.95

1.72 ± 0.85

0.784

RQLQ (score)

 Overall

67.18 ± 8.19

66.81 ± 9.23

0.735

 Activity limitations

9.04 ± 2.88

9.77 ± 3.10

0.226

 Sleep problems

6.12 ± 2.42

6.36 ± 2.34

0.576

 Nasal symptoms

14.24 ± 2.95

13.94 ± 3.00

0.604

 Eye symptoms

5.80 ± 3.02

4.85 ± 3.20

0.128

 Non nose/eye symptoms

14.04 ± 3.48

13.72 ± 3.75

0.702

 Practical problems

10.25 ± 2.54

11.04 ± 3.00

0.123

 Emotional functioning

7.69 ± 2.67

7.13 ± 2.94

0.331

  1. TNSS Total Nasal Symptoms Score, RQLQ Rhinoconjunctivitis Quality of Life Questionnaire